1. Home
  2. ALBT vs NTBL Comparison

ALBT vs NTBL Comparison

Compare ALBT & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALBT
  • NTBL
  • Stock Information
  • Founded
  • ALBT 2014
  • NTBL 2000
  • Country
  • ALBT United States
  • NTBL United States
  • Employees
  • ALBT N/A
  • NTBL N/A
  • Industry
  • ALBT Biotechnology: Biological Products (No Diagnostic Substances)
  • NTBL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALBT Health Care
  • NTBL Health Care
  • Exchange
  • ALBT Nasdaq
  • NTBL Nasdaq
  • Market Cap
  • ALBT 9.5M
  • NTBL 7.5M
  • IPO Year
  • ALBT N/A
  • NTBL N/A
  • Fundamental
  • Price
  • ALBT $0.42
  • NTBL $0.72
  • Analyst Decision
  • ALBT
  • NTBL Strong Buy
  • Analyst Count
  • ALBT 0
  • NTBL 2
  • Target Price
  • ALBT N/A
  • NTBL $7.00
  • AVG Volume (30 Days)
  • ALBT 87.9K
  • NTBL 87.2K
  • Earning Date
  • ALBT 08-12-2024
  • NTBL 08-15-2024
  • Dividend Yield
  • ALBT N/A
  • NTBL N/A
  • EPS Growth
  • ALBT N/A
  • NTBL N/A
  • EPS
  • ALBT N/A
  • NTBL N/A
  • Revenue
  • ALBT $959,516.00
  • NTBL $311,000.00
  • Revenue This Year
  • ALBT N/A
  • NTBL N/A
  • Revenue Next Year
  • ALBT N/A
  • NTBL N/A
  • P/E Ratio
  • ALBT N/A
  • NTBL N/A
  • Revenue Growth
  • ALBT 6.08
  • NTBL N/A
  • 52 Week Low
  • ALBT $0.24
  • NTBL $0.51
  • 52 Week High
  • ALBT $1.70
  • NTBL $10.85
  • Technical
  • Relative Strength Index (RSI)
  • ALBT 44.94
  • NTBL 50.79
  • Support Level
  • ALBT $0.45
  • NTBL $0.69
  • Resistance Level
  • ALBT $0.49
  • NTBL $0.81
  • Average True Range (ATR)
  • ALBT 0.05
  • NTBL 0.06
  • MACD
  • ALBT -0.01
  • NTBL 0.03
  • Stochastic Oscillator
  • ALBT 8.04
  • NTBL 70.96

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

About NTBL Notable Labs Ltd.

Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.

Share on Social Networks: